VivoSim Labs, Inc. cash flow to debt ratio of -2.42K% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

VivoSim Labs, Inc.'s free cash flow has decreased 14.28% from $-9.47M last year to $-10.83M, signaling decreasing performance

VivoSim Labs, Inc.'s debt to equity ratio is -0.13, signaling that the company spent its equity and risk bankruptcy.

VivoSim Labs, Inc.'s debt has increased relative to shareholder equity from 0.09 last year to -0.13 today, signaling weakened financials

VivoSim Labs, Inc. has a net cash position, so leverage is healthy.

VivoSim Labs, Inc. earns at least as much interest as it pays. Interest obligations are fully covered.

VivoSim Labs, Inc.'s profit margin was -1.73K% last year and is -11.02K% this year, signaling decreasing performance

VivoSim Labs, Inc.'s short-term assets of $6.63M exceed its short-term liabilities of $2.79M

VivoSim Labs, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

VivoSim Labs, Inc.'s return on equity of -612.23%, is lower than 15.00%, indicating bad performance

VivoSim Labs, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

VivoSim Labs, Inc. has insufficient public price history to evaluate earnings stability.

VivoSim Labs, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

VivoSim Labs, Inc. has negative free cash flow, indicating cash burn

VivoSim Labs, Inc.'s yearly earnings has decreased 456.39% since last year from $-2.49M to $-13.84M, signaling decreasing performance

VivoSim Labs, Inc.'s yearly revenue has decreased 9.03% since last year from $144.00K to $131.00K, signaling decreasing performance

ROIC -499.16% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

VivoSim Labs, Inc.'s 3-year revenue CAGR of -29.26% is negative, indicating declining revenue over the past 3 years

VivoSim Labs, Inc. has insufficient public price history to evaluate revenue consistency.

VivoSim Labs, Inc. has insufficient public price history to evaluate ROE consistency.

VivoSim Labs, Inc. has insufficient data to evaluate this check.

VivoSim Labs, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

VivoSim Labs, Inc. is overvalued relative to its fair value price of 0.00 based on Base EBITDA Valuation model

VivoSim Labs, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

VivoSim Labs, Inc. has insufficient data to evaluate this check.

VivoSim Labs, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

VivoSim Labs, Inc. has negative shareholder equity; price-to-book is not meaningful and the check fails

VivoSim Labs, Inc. has a price-to-sales ratio of 10.47x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue